Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Thompson

Showing results (581-590 of 637) with videos related to

Pageof 64
Sort By:
Schizophrenia Bulletin|December 10, 2024
Metformin for the Prevention of Antipsychotic-Induced Weight Gain: Guideline Development and Consensus ValidationAoife Carolan, Caroline Hynes-Ryan, Sri Mahavir Agarwal, et al.
Future Medicinal Chemistry|October 23, 2013
Selection and optimization of hits from a high-throughput phenotypic screen against Trypanosoma cruziMartine Keenan, Paul W Alexander, Jason H Chaplin, et al.
Early Intervention in Psychiatry|June 30, 2021
Cannabidiol for at risk for psychosis youth: A randomized controlled trialG Paul Amminger, Ashleigh Lin, Melissa Kerr, et al.
European Journal of Medicinal Chemistry|October 2, 2020
Re-evaluating pretomanid analogues for Chagas disease: Hit-to-lead studies reveal both in vitro and in vivo trypanocidal efficacyAndrew M Thompson, Patrick D O'Connor, Andrew J Marshall, et al.
Biological Psychiatry|November 7, 2019
The NEURAPRO Biomarker Analysis: Long-Chain Omega-3 Fatty Acids Improve 6-Month and 12-Month Outcomes in Youths at Ultra-High Risk for PsychosisG Paul Amminger, Barnaby Nelson, Connie Markulev, et al.
Journal of Medicinal Chemistry|April 28, 2012
Analogues of fenarimol are potent inhibitors of Trypanosoma cruzi and are efficacious in a murine model of Chagas diseaseMartine Keenan, Michael J Abbott, Paul W Alexander, et al.
Journal of Medicinal Chemistry|December 6, 2013
Two analogues of fenarimol show curative activity in an experimental model of Chagas diseaseMartine Keenan, Jason H Chaplin, Paul W Alexander, et al.
International Review of Psychiatry (Abingdon, England)|November 28, 2025
Early intervention for psychiatry itself: the invisible hands for future psychiatryEric Y H Chen, Stephanie M Y Wong, Jimmy Lee, et al.
Schizophrenia Bulletin Open|August 15, 2024
Distress Related to Attenuated Psychotic Symptoms: Static and Dynamic Association With Transition to Psychosis, Nonremission, and Transdiagnostic Symptomatology in Clinical High-Risk Patients in an International Intervention TrialBarnaby Nelson, Hok Pan Yuen, G Paul Amminger, et al.
Frontiers in Psychiatry|June 28, 2019
Relationship Between Polyunsaturated Fatty Acids and Psychopathology in the NEURAPRO Clinical TrialMaximus Berger, Barnaby Nelson, Connie Markulev, et al.
Pageof 64

Showing results (581-590 of 637) with videos related to

Sort By:
Pageof 64
Schizophrenia Bulletin|December 10, 2024
Metformin for the Prevention of Antipsychotic-Induced Weight Gain: Guideline Development and Consensus ValidationAoife Carolan, Caroline Hynes-Ryan, Sri Mahavir Agarwal, et al.
Future Medicinal Chemistry|October 23, 2013
Selection and optimization of hits from a high-throughput phenotypic screen against Trypanosoma cruziMartine Keenan, Paul W Alexander, Jason H Chaplin, et al.
Early Intervention in Psychiatry|June 30, 2021
Cannabidiol for at risk for psychosis youth: A randomized controlled trialG Paul Amminger, Ashleigh Lin, Melissa Kerr, et al.
European Journal of Medicinal Chemistry|October 2, 2020
Re-evaluating pretomanid analogues for Chagas disease: Hit-to-lead studies reveal both in vitro and in vivo trypanocidal efficacyAndrew M Thompson, Patrick D O'Connor, Andrew J Marshall, et al.
Biological Psychiatry|November 7, 2019
The NEURAPRO Biomarker Analysis: Long-Chain Omega-3 Fatty Acids Improve 6-Month and 12-Month Outcomes in Youths at Ultra-High Risk for PsychosisG Paul Amminger, Barnaby Nelson, Connie Markulev, et al.
Journal of Medicinal Chemistry|April 28, 2012
Analogues of fenarimol are potent inhibitors of Trypanosoma cruzi and are efficacious in a murine model of Chagas diseaseMartine Keenan, Michael J Abbott, Paul W Alexander, et al.
Journal of Medicinal Chemistry|December 6, 2013
Two analogues of fenarimol show curative activity in an experimental model of Chagas diseaseMartine Keenan, Jason H Chaplin, Paul W Alexander, et al.
International Review of Psychiatry (Abingdon, England)|November 28, 2025
Early intervention for psychiatry itself: the invisible hands for future psychiatryEric Y H Chen, Stephanie M Y Wong, Jimmy Lee, et al.
Schizophrenia Bulletin Open|August 15, 2024
Distress Related to Attenuated Psychotic Symptoms: Static and Dynamic Association With Transition to Psychosis, Nonremission, and Transdiagnostic Symptomatology in Clinical High-Risk Patients in an International Intervention TrialBarnaby Nelson, Hok Pan Yuen, G Paul Amminger, et al.
Frontiers in Psychiatry|June 28, 2019
Relationship Between Polyunsaturated Fatty Acids and Psychopathology in the NEURAPRO Clinical TrialMaximus Berger, Barnaby Nelson, Connie Markulev, et al.
Pageof 64